Report overview
This report contains market size and forecasts of Creatine Phosphate Sodium API in global, including the following market information:
Global Creatine Phosphate Sodium API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Creatine Phosphate Sodium API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Creatine Phosphate Sodium API companies in 2022 (%)
The global Creatine Phosphate Sodium API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Purity?99% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Creatine Phosphate Sodium API include Luoxin Pharmaceutical, Harbin Laiboten Pharmaceutical, Haikou Qili Pharmaceutical, Jilin Yinglian Biopharmaceutical, Hebei Tiancheng Pharmaceutical, Chongqing Shenghuaxi Pharm, Amicogen China, Kaifeng Mingren Pharmaceuticals and Beijing Polay Pharmaceuticals, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Creatine Phosphate Sodium API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Creatine Phosphate Sodium API Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Creatine Phosphate Sodium API Market Segment Percentages, by Type, 2022 (%)
Purity?99%
Purity<99%
Global Creatine Phosphate Sodium API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Creatine Phosphate Sodium API Market Segment Percentages, by Application, 2022 (%)
Injection
Oral Solid Preparation
Global Creatine Phosphate Sodium API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Creatine Phosphate Sodium API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Creatine Phosphate Sodium API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Creatine Phosphate Sodium API revenues share in global market, 2022 (%)
Key companies Creatine Phosphate Sodium API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Creatine Phosphate Sodium API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Luoxin Pharmaceutical
Harbin Laiboten Pharmaceutical
Haikou Qili Pharmaceutical
Jilin Yinglian Biopharmaceutical
Hebei Tiancheng Pharmaceutical
Chongqing Shenghuaxi Pharm
Amicogen China
Kaifeng Mingren Pharmaceuticals
Beijing Polay Pharmaceuticals
Hainan ChoiteC Pharmaceuticals
Qidong Huatuo Pharmaceutical
